Cargando…
Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
BACKGROUND: Osteopontin (OPN), a member of the small integrin binding ligand N-linked glycoprotein family, has been analyzed in numerous types of human malignancy. PURPOSE: The present study detected the expression levels of OPN and evaluated its role in tumor progression in patients with non-small...
Autores principales: | Ouyang, Xiaoping, Huang, Yumin, Jin, Xing, Zhao, Wei, Hu, Tao, Wu, Feng, Huang, Jianan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157984/ https://www.ncbi.nlm.nih.gov/pubmed/30275702 http://dx.doi.org/10.2147/OTT.S164007 |
Ejemplares similares
-
Plasma Osteopontin Is a Useful Diagnostic Biomarker for Advanced Non-Small Cell Lung Cancer
por: Han, Seon-Sook, et al.
Publicado: (2013) -
Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway
por: Yang, Yi-Fang, et al.
Publicado: (2020) -
Osteopontin regulates the growth and invasion of liver cancer cells via DTL
por: Liu, Zhiyong, et al.
Publicado: (2023) -
Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells
por: Huang, Jianjin, et al.
Publicado: (2012) -
Osteopontin is a prognostic biomarker in non-small cell lung cancer
por: Rud, Ane Kongsgaard, et al.
Publicado: (2013)